Mira Pharmaceuticals Files Q1 2025 10-Q
Ticker: MIRA · Form: 10-Q · Filed: May 14, 2025 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Mira Pharma's Q1 2025 10-Q is in. Check financials.
AI Summary
Mira Pharmaceuticals, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Mira1a Therapeutics, Inc., is based in Miami, Florida. This filing covers the first quarter of 2025, with financial data also presented for the preceding periods.
Why It Matters
This filing provides investors with an update on Mira Pharmaceuticals' financial performance and operational status for the first quarter of 2025, crucial for assessing the company's trajectory.
Risk Assessment
Risk Level: low — This is a standard quarterly filing with no immediate red flags or significant new disclosures.
Key Numbers
- Q1 2025 — Reporting Period (First quarter of 2025)
- 2025-03-31 — Period End Date (End of the reporting quarter)
- 2025-05-14 — Filing Date (Date the report was submitted)
Key Players & Entities
- MIRA PHARMACEUTICALS, INC. (company) — Filer
- Mira1a Therapeutics, Inc. (company) — Former company name
- 20250331 (date) — Reporting period end date
- 20250514 (date) — Filing date
- MIAMI (location) — Business address city
- FL (location) — Business address state
FAQ
What is the primary business of Mira Pharmaceuticals, Inc.?
Mira Pharmaceuticals, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
When was the company formerly known as Mira Pharmaceuticals, Inc.?
The company was formerly known as Mira1a Therapeutics, Inc. and changed its name on January 12, 2022.
What is the business address of Mira Pharmaceuticals, Inc.?
The business address is 1200 BRICKELL AVENUE, SUITE 1950 #1183, MIAMI, FL 33131.
What is the SEC file number for Mira Pharmaceuticals, Inc.?
The SEC file number is 001-41765.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding MIRA PHARMACEUTICALS, INC. (MIRA).